skip to main content

Dispensing duplicate therapy — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateDispensing and SupplyDispensing duplicate therapyGPhC CRA

A patient presents discharge medicines including lansoprazole 30mg daily. The PMR shows omeprazole 20mg daily is still on repeat and due for supply in a weekly tray. What is the legal classification/requirement?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Clarify whether one proton pump inhibitor should be stopped

Lansoprazole and omeprazole are both proton pump inhibitors, so this may be unintended duplicate therapy after discharge. Transitions of care are high-risk for discrepancies. The pharmacist should clarify the intended regimen with the prescriber or discharge information. Supplying both could increase adverse effects without added benefit.

Reference: BNF; GPhC Standards